Abstract
This observational study evaluated the efficacy and tolerability of 3-month aliskiren/amlodipine therapy under outpatient conditions. This Austria-wide observational study included 579 hypertensive patients (566 [98 %] who could be analyzed biometrically) under the care of 140 physicians. The average age of the patient collective was 64 ± 11 years and the mean duration of hypertension was 10 ± 7 years. Regarding 92 % of the study participants, an antihypertensive therapy already existed. Efficacy was assessed in accordance with the Austrian hypertension guidelines while tolerability was evaluated on the basis of adverse events. A descriptive physician judgment based on efficacy, tolerability, and compliance was available for 539 patients (95 %). Office blood pressure values were used for the evaluation. On average, the systolic and diastolic blood pressures were reduced from 161 ± 14 to 135 ± 10 mmHg and 93 ± 9 to 81 ± 6 mmHg, respectively. Blood pressure values of < 140/90 mmHg and < 130/80 mmHg were achieved in 56 and 7 % patients, respectively. A subgroup analysis of 242 patients (43 %) with diabetes mellitus and/or renal disease, as well as those with a high cardiovascular risk, demonstrated nearly identical results compare...Continue Reading
References
Nov 9, 2002·Lancet·Majid EzzatiUNKNOWN Comparative Risk Assessment Collaborating Group
Dec 21, 2002·Lancet·Sarah LewingtonUNKNOWN Prospective Studies Collaboration
Mar 19, 2003·Circulation·Kazuomi KarioKazuyuki Shimada
Nov 26, 2003·Hypertension·Katharina Wolf-MaierMichael Thamm
Jun 23, 2004·Lancet·Stevo JuliusUNKNOWN VALUE trial group
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Sep 13, 2005·Lancet·Björn DahlöfUNKNOWN ASCOT Investigators
Oct 7, 2005·Journal of Hypertension·Boris Lg Van WijkAnthonius de Boer
Feb 16, 2006·Circulation·Bryan WilliamsUNKNOWN CAFE Steering Committee and Writing Committee
Jul 26, 2006·Hypertension·Frans H H LeenenUNKNOWN Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
Oct 6, 2007·The Journal of Clinical Hypertension·Waymon DrummondDeborah L Keefe
Aug 19, 2008·Lancet·Johannes F E MannUNKNOWN ONTARGET investigators
May 22, 2009·Journal of Human Hypertension·P PalatiniD L Keefe
Jan 18, 2011·Lancet·Morris J BrownThomas M MacDonald
Apr 23, 2011·Expert Opinion on Pharmacotherapy·Roberto FogariGiuseppe Derosa
Jun 19, 2013·Wiener klinische Wochenschrift·Claudia FriedlAlexander R Rosenkranz
Jul 3, 2013·Journal of Hypertension·Giuseppe ManciaUNKNOWN Task Force Members
Citations
Jun 10, 2017·Journal of Clinical Medicine·Nikolaos-Dimitrios PantzarisDimitrios Velissaris
Nov 7, 2017·Health Technology Assessment : HTA·Ana DuarteClaire Rothery
Feb 14, 2020·Journal of Hypertension·Konstantinos TsioufisTarek Hassan
May 7, 2020·Journal of Hypertension·Konstantinos TsioufisTarek Hassan